How Real-Time Visibility Is Changing Outsourced Gene Therapy Programs

Outsourced gene therapy programs are increasingly complex, spanning multiple CDMOs, specialized functions, and tightly coupled manufacturing and quality workflows. Despite the high volume of data generated, operational visibility remains fragmented due to disconnected systems, manual reporting processes, and asynchronous communication channels. As a result, sponsors often rely on delayed, partial, and inconsistent views of program status, requiring significant effort to reconstruct a coherent picture of execution. This “black box” effect slows decision-making, increases administrative burden, and reduces confidence in timelines and delivery predictability.

The consequences extend across program execution. Without a shared, real-time reference point, teams interpret progress differently, alignment depends on manual synthesis, and risks are often identified only after they have begun to impact milestones. Dependencies across functions become harder to manage, and governance processes rely heavily on retrospective reporting rather than live operational data.

A real-time integrated operating model addresses these challenges by embedding project governance, execution tracking, and quality and risk data into a unified system. Work is tracked continuously at the task level, linked to defined milestones, and updated at the point of activity. Risks, issues, actions, and decisions are captured alongside execution data, ensuring full traceability and immediate visibility.